Medifast Has Returned 12.6% Since SmarTrend Recommendation (MED)
Comtex SmarTrend(R) - Fri Apr 11, 11:14AM CDT
SmarTrend identified an Uptrend for Medifast (NYSE:MED) on March 17th, 2014 at $27.62. In approximately 4 weeks, Medifast has returned 12.64% as of today's recent price of $31.11.
3 Stocks to Get on Your Watchlist
Sean Williams, The Motley Fool - Motley Fool - Wed Apr 09, 4:08PM CDT
I follow quite a lot of companies, so the usefulness of a watchlist for me cannot be overstated. Without my watchlist, I'd be unable to keep up with my favorite sectors and see what's really moving the market. Even worse, I'd be lost when the time...
Medifast, Inc. Announces Analyst Day Presentation
PR Newswire - Tue Apr 08, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today announced it will host an analyst day with Chairman and Chief Executive Officer Michael C. MacDonald and other members of Medifast's senior management team on Tuesday, April 22, 2014 at 9:00 a.m. ET in New York, NY.
Medifast Announces Winner of March Fly Away Contest
PR Newswire - Mon Apr 07, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs is pleased to announce Marlene Williams of Austin, TX as the winner of the March fly away contest in partnership with The V Foundation for Cancer Research, one of the nation's leading cancer research funding organizations. Williams has won the grand-prize package, which includes two (2) round-trip air transportation tickets, five (5) nights lodging, two (2) tickets to the final games in Dallas, and two (2) tickets to the charity concert at Gilley's in Dallas.
Medifast (MED) is Overbought, What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 7:59AM CDT
Medifast (MED) is Overbought, What’s Next?
How Increased Brand Awareness and a Multichannel Strategy Will Propel This Company's Growth
Mark Lin, The Motley Fool - Motley Fool - Tue Apr 01, 1:53PM CDT
Source: Medifast Two-thirds of the U.S. population is considered either overweight or obese, according to industry data compiled by Medifast , a distributor of weight loss and weight management products. Last year, the American Medical...
Medifast's partner expands in Latin America with acquisition of 13 weight management clinics in Mexico City
M2 - Wed Mar 26, 3:06AM CDT
Medifast Inc (NYSE:MED), a manufacturer and provider of clinically proven, portion-controlled weight-loss products and programmes, announced on Tuesday that Medix, a Medifast strategic partner and a pharmaceutical manufacturer and distributor in Latin America, has acquired 13 Slim Centres, a weight management chain, in Mexico City.
Medifast Announces Medix Expansion in Latin America
PR Newswire - Tue Mar 25, 3:30PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Medix, a Medifast strategic partner and leading pharmaceutical manufacturer and distributor in Latin America, acquired 13 Slim Centers in Mexico City.
Medifast Launches Flavors of Home(TM) Meals
PR Newswire - Tue Mar 25, 3:15PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is proud to announce a new line of meals to complement Medifast's many weight-loss and weight management programs. The new Flavors of Home(TM) line will feature three meal choices: Turkey Meatball Marinara, Chicken with Rice & Vegetables and Chicken Cacciatore.
NYSE stocks posting largest percentage increases
AP - Tue Mar 18, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Medifast CFO Named Top Baltimore Executive By SmartCEO
PRWeb - Tue Mar 18, 8:18AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is proud to announce that its Chief Financial Officer, Timothy Robinson, has been recognized with SmartCEO's Executive Management Award.
Market Expansions, Investor Forums, Innovation Awards, Amended Credit Facilities, and Dividend - Analyst Notes on Medifast, HSN, Office Depot, KAR, and Rent-A-Center
PR Newswire - Fri Mar 14, 7:56AM CDT
Today, Analysts Review released its analysts' notes regarding Medifast Inc. (NYSE: MED), HSN, Inc. (NASDAQ: HSNI), Office Depot, Inc. (NYSE: ODP), KAR Auction Services, Inc. (NYSE: KAR), and Rent-A-Center Inc. (NASDAQ: RCII). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Medifast (MED) in Focus: Stock Moves 8.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:46AM CDT
Medifast was a big mover last session, with shares rising just over 8% on the day.
NYSE stocks posting largest volume increases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
Why Shares of Medifast Inc. Jumped
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Mar 11, 4:01PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Medifast Inc. were looking healthier...
Short Squeeze Staring on Medifast (MED)
M2 - Tue Mar 11, 9:37AM CDT
March 11, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Medifast (NYSE: MED). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $24.23 and the projected fundamental valuation of $39.72.
Medifast to expand into Canada in Q1 2014
M2 - Tue Mar 11, 6:54AM CDT
US-based Medifast Inc (NYSE:MED), a nutrition and weight-loss company, announced on Monday plans to expand its international presence by launching in Canada in Q1 2014.